Listeria innocua is widespread in the environment and in food. This species has to date never been described in association with human disease. We report a case of fatal bacteremia caused by L. innocua in a 62-year-old patient.
gram-positive rods with a coryneform appearance. After 24 h of incubation, the colonies were small, white, and nonhemolytic on sheep blood agar plates. Among the positive reactions were catalase production, rapid esculin hydrolysis, and production of acid from glucose, maltose, and lactose. With the use of the Api Coryne system (Biomerieux), the numerical profile 2170164 was obtained, which in the API Plus version 2.0 database corresponds to a "good identification" of Listeria monocytogenes and/or L. innocua. In order to differentiate between the two species, the following tests were used: evaluation of acid production from D-xylose, L-rhamnose, D-mannitol, and alpha-methyl-D-mannoside by using the Api 50 CH system (Biomerieux); a CAMP test using beta-hemolysin-producing Staphylococcus aureus (ATCC 25923); and a rapid slide test using the L. monocytogenes polyvalent antiserum (Difco). Results are shown in Table 1 . In consideration of the origin of the strain (blood culture), the severity of the disease (septic shock), and the biochemical characteristics of the isolate, presumptive identification of L. monocytogenes was given, and the strain was sent to the national Listeria reference laboratory (Pasteur Institute, Paris, France) for definitive identification and serotyping. The isolate was, surprisingly, identified as L. innocua serovar 6a. An Api Listeria system test (Biomerieux) was rapidly performed. The profile obtained (7510) identified the isolate as L. innocua with 99.6% probability. A sequence analysis of the 16S rRNA gene was finally done using the MicroSeq 500 16S rDNA bacteria sequencing kit with an automated DNA sequencer (ABI PRISM 310 sequencer), both from Perkin-Elmer Applied Biosystems (Courtabeuf, France). The sequence obtained (523 bp) was compared to all bacterial sequences available from the GenBank database by using the BLAST program (National Center for Biotechnology Information). The analysis showed 100% identity between the isolate and four published L. innocua sequences (GenBank accessionno. AL596173, AL596172, AL596170, and AL596164) and 99.62% similarity between the isolate and L. monocytogenes (GenBank accession no. AL591983).
Of the Listeria species, only L. monocytogenes is considered to be a significant human and animal pathogen, even though occasional human infections caused by L. welshimeri, L. seeligeri, and L. ivanovii have been reported (1, 3, 9) . Widespread in the environment and in food, L. innocua is considered to be a nonpathogenic bacterium (1).
On the microbiological side, the only phenotypic characteristic that classically distinguishes L. monocytogenes from L. innocua is hemolysis (4, 8) . However, the hemolytic activity of L. monocytogenes may be weak, especially with low-producing strains, and questionable hemolytic reaction has been reported with some L. innocua strains when nonselective culture with brain heart infusion agar was used (5). Moreover, nonhemolytic L. monocytogenes strains have been recently described (2) . The use of the CAMP test, proposed to enhance hemolytic activity of L. monocytogenes, does not always resolve the problem: ambiguous hemolysis has been noticed with several L. monocytogenes strains, even with the use of conventional sheep blood agar plates (6) . Thus, distinguishing between L. monocytogenes and L. innocua on the basis of hemolytic activity is a risk. Rapid slide test with Listeria O polyvalent antiserum (recommended for a rapid identification of L. monocytogenes, since it is able to detect Listeria serovars 1, 4, 2, and 3) (Difco) should be avoided because of lack of specificity. Indeed, a distinct agglutination was noticed, although the strain was of serovar 6a, which was incompatible with L. monocytogenes.
Since a few years ago, the Api Listeria system (Biomerieux) has provided a useful help for differentiating between L. monocytogenes and L. innocua on the basis of the absence of arylamidase (differentiation of L. innocua and L. monocytogenes [DIM] test) from the former (4). In our case, the Api Listeria system has given, easily and rapidly, the correct identification.
The clinical case reported here is unusual for several reasons. Bacteria encountered in cases of acute cholangitis are usually gram-negative rods such as Escherichia coli or Klebsiella spp. or sometimes gram-positive cocci (Enterococcus or Streptococcus), seldom anaerobes (7), and the initial antibiotherapy given was active against most of these species except Enterococcus. Gram-positive rods have never been reported. Most of these rods are susceptible to cefotaxime, except those of the genus Listeria, which are naturally resistant to this antibiotic. Second, among the Listeria species, only L. monocytogenes is widely known to be able to cause severe disease. L. seeligeri has been documented recently to have caused acute meningitis in an immunocompetent host (9) . As for L. innocua, this is, to our knowledge, the first description of a human infection caused by this bacterium. Third, our patient was not known to be immunocompromised. Only inhaled corticoids taken to treat asthma could have led to some immunodeficiency. Thus, that L. innocua infection could lead to a fatal outcome was totally unexpected.
Finally, our report constitutes the first documentation of a case of bacteremia due to L. innocua and makes us keep in mind that, in blood cultures, the Listeria species encountered is not always L. monocytogenes.
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